Too Much “High-Energy Visible Light” Screen Time May Cause Macular Degeneration

eye damage from tabletExcessive time spent in front of a computer, smartphone, or tablet screen can increase risk of macular degeneration, especially in young people.

The AOA’s survey focused on how much time parents thought their children spent on handheld devices. Their responses easily underestimated those of the children, aged 10 to 17, who reported (83%) that they use a handheld device for at least three hours a day, with 32 percent looking at a screen for more than an hour without glancing Continue reading

Iodine Supplement May Help Retinitis Pigmentosa Swelling – Cystoid Macular Edema (CME)

iodine supplementResearch suggests that individuals with retinitis pigmentosa (RP) may benefit from a dietary iodine supplement. RP patients often experience retinal swelling as a result of Cystoid Macular Edema (CME). A study published in JAMA Ophthalmology showed swelling due to CME to be inversely related to iodine intake.

The study was conducted by researchers from Massachusetts Eye and Ear, Harvard Medical School, and Boston University School of Medicine. Using a Continue reading

Turmeric May Guard Against Cancer, Lupus, Diabetes

tumericResearch on turmeric spice indicates its potential to fight depression, cancer, diabetes, and neurodegenerative disease. The bright yellow spice, which lends color and flavor to mustard, curry, and other foods, also contains highly beneficial chemicals like curcumin.

Curcumin has been studied widely in the past, but it only makes up about two to five percent of the turmeric spice. Researchers from the Cytokine Research Laboratory Continue reading

Central Serous Choroidopathy/Retinopathy: Leaks that Damage the Eye

retina exam can detect Central Serous Choroidopathy/RetinopathyCentral Serous Choroidopathy, also known as Central Serous Retinopathy (CSR) and Central Serous Chorioretinopathy (CSC), is an eye condition which causes visual impairment. It usually occurs in one eye, and it is usually temporary. But studies show that both eyes are affected on a cellular level even when damage is only apparent in one eye.

CSC is characterized by fluid leakage beneath the retina. Fluid leaks from the layer of the eye called the choroid. This is a heavily vascularized membrane that nourishes the Continue reading

New Book: Stem Cells Heal Your Eyes – Macular Degeneration and More

stem cells book coverHow can you prevent and reverse serious eye disease using stem cells? A new book by Damon P Miller II MD, Carlyle Coash MA, and Adam Miller examines the potential for stem cells to address macular degeneration, retinitis pigmentosa, Stargardt’s disease and other retinopathies. This up-and-coming area of medicine looks at research in Epigenetics and adult stem cells, and how they could help eye functioning. Learn more and buy the paperback or Kindle edition of Stem Cells Heal Your Eyes: Prevent and Help: Macular Degeneration, Retinitis Pigmentosa, Stargardt, Retinal Distrophy, and Retinopathy on Amazon.com.

Eye Tests May Predict Early Alzheimer’s Disease

Alzheimer's diseaseEarly trials of two types of eye tests show promising results in identifying Alzheimer’s Disease in its early stages. Research showed that a key protein can be detected in the retina and lens of the eye through simple tests. Both types of eye tests accurately distinguished healthy patients from those with early stages of Alzheimer’s, which was confirmed by PET (positron-emission tomography) scans.

In one trial, Australian researchers asked 200 participants to take a supplement of curcumin, an ingredient of turmeric spice. Continue reading

New Study on Squalamine Eye Drops for Wet Macular Degeneration

eye-drop-amd-2A new clinical trial showed positive results for patients with wet age-related macular degeneration (AMD). The study, which monitored the use and performance of Squalamine eye drops, showed improvement in a number of visual functions.

Conducted by Ohr Pharmaceutical, the nine-month research was a Phase II clinical trial that tested for the effectiveness of Squalamine eye drops in improving visual function. All patients had administered eye drops two times per day, either Squalamine or a placebo, plus injections of Continue reading

Diabetic Retinopathy Guide: When High Blood Sugar Damages the Eyes

diabetic risk to the eyesDiabetic retinopathy is an eye disease that is a complication of diabetes. In diabetes, levels of blood sugar are chronically elevated due to lack of insulin, an insulin  insensitivity, or a combination of both. Just as sugar combined with water outside the body forms a sticky substance, excessive sugar in the bloodstream does so as well. Sugar adheres to numerous different tissues in the body, causing problems depending on the tissue. Prolonged excessive sugar in the bloodstream tends to damage the blood vessels of the retina, the back part of the eye that sends light signals to the brain. As the blood vessels Continue reading

Eye Infections: A Guide to Keratitis, Pink Eye (Conjunctivitis) and More

eye infections - bacteriaEye infections are a result of invasion of any part of the eye by disease-causing microorganisms. These include certain pathogens that can invade the eyelid, the conjunctiva, the cornea and, in severe and serious cases, inner parts of the eye as well. Eye infections can affect one or both eyes. Although an eye infection can seem mild, it is important to get proper diagnosis and treatment to prevent potentially serious injury to the eye.

Types of Eye Infections

Pink Eye or Conjunctivitis – In the Western Continue reading

New Vision Training for Glaucoma

computer-based eye trainingNew research indicates a breakthrough in repairing vision for patients with glaucoma. A clinical trial published in JAMA Ophthalmology showed vision improvement from daily computer-based training. Retinal damage due to glaucoma is considered irreversible, but this research indicates vision restoration is possible. By continually activating patients’ residual vision, computer training may be able to strengthen vision.

The clinical trial, conducted by Drs. J. Gublin and B. A. Continue reading